Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited to the skin and can cause many types of rashes and lesions. Drug-induced lupus erythematosus This is a ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN: Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 2011; 20: 1187–92 CrossRef MEDLINE e4.

Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread inflammation and tissue damage that can affect any part of the body. Commonly affected ...

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD, a group of intestinal disorders that cause inflammation of the digestive tract) share a common set of microbiome features that ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

Monitoring and supplementing maternal 25(OH) vitamin D levels in patients with lupus within the 40-59 ng/mL range are crucial while preventing excessive supplementation, this study suggested.

People with lupus often need to use medicines to manage their symptoms. Although there are many oral medicines that treat lupus, some people with more severe symptoms may not get enough benefit ...

Biogen and UCB said Tuesday that an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal of a placebo-controlled Phase 3 study. Detailed study ...